China's drug development sector struck $138 billion in out-licensing deals last year — more than the United States for the first time. Yet behind the headline numbers, a growing number of biotech boards admit they cannot find the executives to run the programs. SunTzu Recruit, a China-based executive search firm, estimates the search for a Shanghai-based Chief Medical Officer with global trial experience now takes eight to ten months.